Atara Biotherapeutics, Inc. (ATRA): Total Liabilities
$58.74M
As of 2025-12-31
$58.02M
As of 2026-06-30
-38.3%
3-year compound annual growth
-14.1%
5-year compound annual growth
+19.5%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $58.74M | -71.5% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $206.38M | -22.0% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $264.74M | +6.0% | 2025-03-07, Balance as of period end |
| 2022-12-31 | $249.78M | +32.5% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $188.51M | +49.9% | 2023-02-08, Balance as of period end |
| 2020-12-31 | $125.78M | +141.1% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $52.16M | -1.5% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $52.98M | +32.7% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $39.91M | +292.2% | 2019-02-26, Balance as of period end |
| 2016-12-31 | $10.18M | +3.1% | 2018-02-27, Balance as of period end |
| 2015-12-31 | $9.88M | +235.9% | 2017-03-09, Balance as of period end |
| 2014-12-31 | $2.94M | +67.6% | 2016-03-04, Balance as of period end |
| 2013-12-31 | $1.75M | n/a | 2015-02-26, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | $58.74M | -71.5% |
| Monte Rosa Therapeutics, Inc. (GLUE) | 2025-12-31 | $215.60M | -0.1% |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | $1.00B | +15.0% |
| Century Therapeutics, Inc. (IPSC) | 2025-12-31 | $64.77M | -66.2% |
| Beam Therapeutics Inc. (BEAM) | 2025-12-31 | $242.82M | -34.4% |
| Sutro Biopharma, Inc. (STRO) | 2025-12-31 | $306.28M | -10.6% |
| Ginkgo Bioworks Holdings, Inc. (DNA) | 2025-12-31 | $611.11M | -7.6% |
| REGENXBIO Inc. (RGNX) | 2025-12-31 | $350.30M | +69.8% |
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | $61.05M | +22.6% |
Compare ATRA, GLUE, IBRX, IPSC side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗